Marc C Levesque

Marc C Levesque

UNVERIFIED PROFILE

Are you Marc C Levesque?   Register this Author

Register author
Marc C Levesque

Marc C Levesque

Publications by authors named "Marc C Levesque"

Are you Marc C Levesque?   Register this Author

58Publications

1028Reads

41Profile Views

Longitudinal Reliability of the OMERACT Thumb Base Osteoarthritis Magnetic Resonance Imaging Scoring System (TOMS).

J Rheumatol 2019 Sep 15;46(9):1228-1231. Epub 2018 Dec 15.

From the Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands; Paris 6, Sorbonne Universités, GRC-08 (EEMOIS); AP-HP, Department of Rheumatology, Pitié Salpêtrière University Hospital, Paris, France; Spire Sciences Inc., Boca Raton, Florida; Data and Statistical Sciences, and Immunology Development, AbbVie Inc., North Chicago, Illinois; Departments of Radiology and Medicine, University of California at San Francisco, San Francisco, California; AbbVie Inc., Cambridge, Massachusetts, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and National Institute for Health Research, Leeds Biomedical Research Centre, Leeds, UK; Department of Diagnostic Imaging, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180949DOI Listing
September 2019

Timing and Impact of Decisions to Adjust Disease-Modifying Antirheumatic Drug Therapy for Rheumatoid Arthritis Patients With Active Disease.

Arthritis Care Res (Hoboken) 2018 06 16;70(6):834-841. Epub 2018 Apr 16.

University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862728PMC
June 2018

Rheumatoid Arthritis Patients' Motivations for Accepting or Resisting Disease-Modifying Antirheumatic Drug Treatment Regimens.

Arthritis Care Res (Hoboken) 2018 04 11;70(4):533-541. Epub 2018 Mar 11.

University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23301DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712284PMC
April 2018

Soluble biochemical markers of osteoarthritis: Are we close to using them in clinical practice?

Best Pract Res Clin Rheumatol 2017 10 11;31(5):705-720. Epub 2018 Sep 11.

The D-BOARD FP7 Consortium(1), European Union; The APPROACH IMI Consortium(2), European Union; Bone and Cartilage Research Unit, Arthropôle Liege, University of Liège, Liège, Belgium; Physical Therapy and Rehabilitation Department, Princess Paola Hospital, Vivalia, Marche-en-Famenne, Belgium.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216942183002
Publisher Site
http://dx.doi.org/10.1016/j.berh.2018.07.002DOI Listing
October 2017

Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases.

J Allergy Clin Immunol 2017 09 12;140(3):685-687. Epub 2017 May 12.

Gilead Sciences, Foster City, Calif.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2017.04.029DOI Listing
September 2017

Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.

Rheumatology (Oxford) 2016 09 6;55(9):1710. Epub 2016 Jul 6.

Division of Rheumatology and Clinical Immunology, University of Pittsburgh Department of Medicine, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kew275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795378PMC
September 2016

Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.

Rheumatology (Oxford) 2016 06 16;55(6):991-9. Epub 2016 Feb 16.

Division of Rheumatology and Clinical Immunology, University of Pittsburgh Department of Medicine, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kev444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281030PMC
June 2016

IgG4-Related Lung Disease Associated with Usual Interstitial Pneumonia.

Open Rheumatol J 2016 17;10:33-8. Epub 2016 Mar 17.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1874312901610010033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797687PMC
April 2016

Agreement of Physicians and Nurses Performing Tender and Swollen Joint Counts in Rheumatoid Arthritis.

J Clin Rheumatol 2016 Jan;22(1):30-4

From the *School of Nursing, University of Pittsburgh; †School of Medicine, University of Pittsburgh; ‡University of Pittsburgh Medical Center; and §Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA; and ∥AbbVie, Worcester, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000324DOI Listing
January 2016

Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab.

Clin Exp Rheumatol 2015 Sep-Oct;33(5):655-63. Epub 2015 Oct 5.

Department of Pediatrics, Duke Children's Hospital, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
December 2015

Anti-signal recognition particle autoantibody ELISA validation and clinical associations.

Rheumatology (Oxford) 2015 Jul 17;54(7):1194-9. Epub 2014 Dec 17.

Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keu436DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473763PMC
July 2015

Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.

Int J Rheum Dis 2015 Jul 11;18(6):646-53. Epub 2015 May 11.

Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/1756-185X.12636
Publisher Site
http://dx.doi.org/10.1111/1756-185X.12636DOI Listing
July 2015

20-year-old amish woman with abdominal pain, retroperitoneal mass, and hyperlipidemia.

Arthritis Care Res (Hoboken) 2015 Mar;67(3):447-51

University of Pittsburgh, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22425DOI Listing
March 2015

Complement component C5a permits the coexistence of pathogenic Th17 cells and type I IFN in lupus.

J Immunol 2014 Oct 22;193(7):3288-95. Epub 2014 Aug 22.

Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1401322DOI Listing
October 2014

Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients.

J Invest Dermatol 2013 Dec 3;133(12):2786-2788. Epub 2013 Jun 3.

Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022202X153606
Publisher Site
http://dx.doi.org/10.1038/jid.2013.236DOI Listing
December 2013

Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?

Authors:
Marc C Levesque

BioDrugs 2012 Apr;26(2):65-70

Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11631320-000000000-00000DOI Listing
April 2012

JAK inhibition in rheumatoid arthritis.

Curr Rheumatol Rep 2011 Oct;13(5):379-80

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-011-0196-4DOI Listing
October 2011

Inhibition of spleen tyrosine kinase for rheumatoid arthritis.

Curr Rheumatol Rep 2011 Oct;13(5):377-8

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-011-0195-5DOI Listing
October 2011

Cost-effectiveness of biologics compared with disease-modifying antirheumatic drugs in rheumatoid arthritis.

Curr Rheumatol Rep 2011 Oct;13(5):381-2

Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-011-0197-3DOI Listing
October 2011

Clinical course of Crohn's disease following treatment of lymphoma.

Inflamm Bowel Dis 2011 Jun 23;17(6):1265-9. Epub 2011 Feb 23.

Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.21487DOI Listing
June 2011

NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans.

Hum Genet 2009 Nov 3;126(5):643-53. Epub 2009 Jul 3.

Dr. John T. Macdonald Foundation Department of Human Genetics, Miami Institute of Human Genomics, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00439-009-0713-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881538PMC
November 2009

Oligoclonal TRBV gene usage among CD8(+) T cells in monoclonal B lymphocytosis and CLL.

Br J Haematol 2009 May 2;145(4):535-7. Epub 2009 Mar 2.

Department of Medicine, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2009.07635.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754701PMC
May 2009

CLL cell apoptosis induced by nitric oxide synthase inhibitors: correlation with lipid solubility and NOS1 dissociation constant.

Leuk Res 2008 Jul 3;32(7):1061-70. Epub 2008 Jan 3.

Department of Medicine, Division of Rheumatology and Clinical Immunology, Duke University and Durham VA Medical Centers, Durham, NC 27710, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2007.11.026DOI Listing
July 2008

Normative values for exhaled breath condensate pH and its relationship to exhaled nitric oxide in healthy African Americans.

J Allergy Clin Immunol 2008 Jul 12;122(1):101-6. Epub 2008 May 12.

Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Ohio State University Medical Center, Columbus, Ohio 43221, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2008.03.024DOI Listing
July 2008

Determinants of exhaled nitric oxide levels in healthy, nonsmoking African American adults.

J Allergy Clin Immunol 2008 Feb 26;121(2):396-402.e3. Epub 2007 Nov 26.

Department of Medicine, Division of Rheumatology and Immunology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2007.09.031DOI Listing
February 2008

B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.

J Allergy Clin Immunol 2008 Jan;121(1):13-21; quiz 22-3

Department of Medicine, Division of Rheumatology and Immunology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2007.11.030DOI Listing
January 2008

Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.

Am J Hematol 2007 Dec;82(12):1063-70

Department of Medicine, Division of Hematology, VA and Duke University Medical Centers, 508 Fulton Street, Durham, North Carolina 27705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.20987DOI Listing
December 2007

Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels.

Leuk Res 2006 Jan 21;30(1):24-8. Epub 2005 Jul 21.

Department of Medicine, Division of Rheumatology, Duke University and Durham VA Medical Centers, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2005.05.022DOI Listing
January 2006

The dichotomous role of nitric oxide in the pathogenesis of accelerated atherosclerosis associated with systemic lupus erythematosus.

Curr Mol Med 2004 Nov;4(7):777-86

From Department of Medicine, Division of Rheumatology, Duke University and Durham VA Medical Centers, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1566524043359872DOI Listing
November 2004

Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production.

Lancet 2003 Feb;361(9358):676-8

Division of Infectious Diseases, VA and University of Utah Medical Centers, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(03)12564-0DOI Listing
February 2003

Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans.

J Rheumatol 2003 Jan;30(1):60-7

Department of Medicine, Ralph H. Johnson VA Medical Center (VAMC) and Medical University of South Carolina, Charleston 29425, USA.

View Article

Download full-text PDF

Source
http://www.jrheum.org/content/30/1/60.full.pdf
Web Search
January 2003